Pyridoxal 5'-phosphate (PLP / P5P)

Physiological Role

Pyridoxal 5'-phosphate, abbreviated PLP or P5P, is the metabolically active form of vitamin B6. Once absorbed, dietary pyridoxine is phosphorylated in the liver by pyridoxal kinase, a zinc-dependent enzyme, then oxidized to PLP by pyridoxine-5'-phosphate oxidase, whose cofactor derives from riboflavin. This active form circulates bound to plasma albumin before being used by tissues.

PLP acts as a cofactor for more than 100 enzymes. It is involved in transamination, a key step in amino acid metabolism, in the decarboxylation of neurotransmitter precursors (serotonin, dopamine, GABA), and in the synthesis of heme, the core of red blood cells. These reactions affect cellular energy, mood regulation, and oxygen transport.

PLP is also a central player in the methylation cycle and one-carbon metabolism. It is the cofactor of cystathionine beta-synthase, the enzyme that converts homocysteine to cystathionine through the transsulfuration pathway. This function makes it complementary to vitamins B9 and B12 in regulating plasma homocysteine.

Reference Ranges

Depending on the biomarker, Singular ranges are based on a synthesis of nutritional or clinical reference points and longevity research. They do not replace your laboratory's reference values or your healthcare professional's advice.

Biological Significance

A PLP value in the optimal zone reflects satisfactory functional availability of vitamin B6 for the tissues. It supports amino acid transamination, neurotransmitter production, and homocysteine regulation.

A low PLP reflects suboptimal B6 status. In the NHANES survey, close to three adults in ten, supplemented or not, have a PLP below 30 nmol/L, the adequacy reference used by EFSA, usually without anything noticeable. Low values are more frequent in older adults, oral contraceptive users, in cases of chronic inflammation, or with insufficient dietary intake.

A dose-response analysis of the NHANES cohort shows that all-cause mortality decreases gradually as PLP rises. The inflection point sits near 43 nmol/L. Above this threshold, the benefit extends to cardiovascular risk. This justifies aiming for an optimal zone rather than the mere absence of low values.

A very high PLP is most often a marker of recent vitamin B6 supplementation. It is not associated with increased risk at usual dietary or nutritional doses. Reading PLP gains accuracy when combined with homocysteine, hs-CRP, and albumin, since these markers shape its interpretation.

Influencing Factors

Diet. The richest food sources of vitamin B6 are poultry, fish (especially salmon and tuna), banana, potato, legumes, and nuts. A diet low in animal protein and minimally processed plant foods exposes to a marginal PLP.

Medications. Several molecules interfere with PLP metabolism. Isoniazid, an anti-tuberculosis drug, forms a complex with PLP that inactivates it. Hydralazine, theophylline, and some oral contraceptives can also lower plasma concentrations. Prolonged use of these medications is therefore part of the context in which a low PLP is read.

Chronic inflammation. Inflammatory markers such as hs-CRP are inversely correlated with PLP. When systemic inflammation rises, PLP is mobilized to inflammatory sites for the kynurenine pathway, which lowers its circulating level independently of dietary intake.

Physical activity. PLP is the prosthetic group of muscle glycogen phosphorylase, the enzyme that mobilizes glycogen: muscle is the body's main PLP reservoir. Highly active individuals often have increased vitamin B6 needs.

Age. PLP status tends to decline with age, due to less efficient intestinal absorption, increased tissue consumption, and a higher prevalence of polypharmacy.

Genetics. Variants in PLP metabolism enzymes, particularly pyridoxal kinase and the phosphatases involved in its cycle, modulate the conversion between active and inactive forms.

Supplementation. The pyridoxal-5-phosphate (P5P) included in the Singular formula is the coenzyme vitamer, the one enzymes bind to; its activation route uses only pyridoxal kinase, without the additional oxidation step that pyridoxine requires. Vitamin B12 as methylcobalamin and vitamin B9 as 5-MTHF act synergistically on the methylation cycle. They may indirectly influence PLP readings.

In the Singular Formula

PLP plays a central role in personalizing the Singular formula. The formulation engine uses it to calibrate the dosage of vitamin B6 and to coordinate methylation cycle support.

When PLP falls in the very low zone, vitamin B6 (P5P) dosage is set to its strongest level. This adjustment assumes an albumin and an alkaline phosphatase compatible with a reliable PLP reading. When PLP is low, dosage is intermediate. When PLP sits in the lower part of the optimal zone, a maintenance dose is kept to preserve status. The P5P used in the formula is the coenzyme vitamer, the one enzymes bind to. Its activation proceeds through phosphorylation by pyridoxal kinase, without the additional oxidation step that pyridoxine requires.

Two conditions raise vitamin B6 to its reinforced dosage: elevated homocysteine, and a PLP that does not exceed the first third of its optimal zone or that the laboratory did not report. This calibration is consistent with the recognized role of vitamin B6 in normal homocysteine metabolism. This logic is completed by vitamin B9 as 5-MTHF and vitamin B12 as methylcobalamin. Together with vitamin B6, these three bioactives act on the one-carbon cycle.

A safety rule applies when albumin is low or when alkaline phosphatase is very high, since these situations make PLP interpretation more difficult. The engine then keeps a maintenance dose rather than marked supplementation, unless homocysteine is itself elevated: in that case the methylation rule applies and the dosage stays reinforced. This cross-reading with homocysteine, albumin, and alkaline phosphatase illustrates the systemic approach of Singular: a single biomarker is never read in isolation.

Scientific Studies

Frequently Asked Questions